ArticleBioinformatics advances2026
Node2Vec-DGI-EL: a hierarchical graph representation learning model for ingredient-disease association prediction.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Traditional Chinese medicine, as an essential component of traditional medicine, contains active ingredients that serve as a crucial source for modern drug development. To explore the potential application value of traditional Chinese medicine ingredients, this study utilizes the complex network formed between herbs, ingredients, targets, and diseases, and proposes an ingredient-disease association prediction model (Node2Vec-DGI-EL) based on hierarchical graph representation learning. The model first utilized Node2Vec to extract node embedding vectors, serving as the initial features for the network nodes. Then, DGI was applied to further refine the node representations, enhancing the model's expressive power. Finally, an ensemble learning method was integrated to further improve prediction performance. Results: The proposed model significantly outperformed existing methods, achieving an AUC of 0.9987 and an AUPR of 0.9545. Case studies further validated the reliability of the model's predictive results. Specifically, triptonide exhibited a binding energy of -9.62 kcal/mol with PGR, a core target of hypertensive retinopathy, while methyl ursolate showed a binding energy of -9.71 kcal/mol with NFE2L2, a core target of colorectal cancer. The Node2Vec-DGI-EL model focuses on traditional Chinese medicine datasets, effectively predicting ingredient-disease associations. It demonstrates significant application value and can assist in drug repositioning and novel drug development. Availability and implementation: The code and data are available at https://github.com/wayfarer569/Node2Vec-DGI-EL.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.